NEW YORK (GenomeWeb) – Molecular diagnostics firm Diamir announced today that it has formed a research collaboration with Janssen Pharmaceuticals, a unit of Johnson & Johnson, for the potential development of a microRNA-based companion diagnostic for neurodegenerative disease drug candidates.

Founded in 2009, Diamir is using its technology to develop assays that use blood-based miRNA signatures to diagnose neurodegenerative conditions including Alzheimer's disease, Parkinson's disease, and mild cognitive impairment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.